S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Endava (DAVA) Earnings Date, Estimates & Call Transcripts

$67.77
+0.89 (+1.33%)
(As of 11/29/2023 ET)
Compare
Today's Range
$67.09
$68.95
50-Day Range
$48.50
$67.77
52-Week Range
$44.62
$95.00
Volume
232,953 shs
Average Volume
297,778 shs
Market Capitalization
$3.91 billion
P/E Ratio
43.72
Dividend Yield
N/A
Price Target
$74.13

Earnings Summary

Upcoming
Earnings Date
Feb. 13Estimated
Actual EPS
(Nov. 15)
$0.39 Beat By $0.04
Consensus EPS
(Nov. 15)
$0.35
Skip Charts & View Estimated and Actual Earnings Data

DAVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DAVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Endava Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q2 20232$0.44$0.51$0.48$0.65 - $0.67
Q3 20232$0.48$0.53$0.51$0.64 - $0.66
Q4 20231$0.52$0.52$0.52$0.55 - $0.57
20235$1.44$1.56$1.50 
Q1 20241$0.68$0.68$0.68$0.43 - $0.44
Q2 20241$0.32$0.32$0.32$0.34 - $0.35
Q3 20242$0.52$0.61$0.57 
Q4 20241$0.50$0.50$0.50 
FY 20245$2.02$2.11$2.07 
Q1 20251$0.47$0.47$0.47 
Q2 20251$0.48$0.48$0.48 
Q4 20251$0.56$0.56$0.56 

DAVA Earnings Date and Information

Endava last posted its quarterly earnings data on November 15th, 2023. The reported $0.39 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.04. The company had revenue of $188.40 million for the quarter, compared to analysts' expectations of $186.47 million. Its revenue was down 4.0% on a year-over-year basis. Endava has generated $1.55 earnings per share over the last year ($1.55 diluted earnings per share) and currently has a price-to-earnings ratio of 43.7. Earnings for Endava are expected to grow by 64.75% in the coming year, from $1.22 to $2.01 per share. Endava has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 13th, 2024 based off prior year's report dates.

Endava Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/13/2024
Estimated)
------- 
11/15/2023Q3 2023$0.35$0.39+$0.04$0.23$186.47 million$188.40 million    
9/19/2023Q4 2023$0.45$0.57+$0.12$0.50$188.53 million$189.80 million    
5/23/2023Q3 2023$0.46$0.51+$0.05$0.51$233.78 million$247.28 million
2/14/2023Q2 2023$0.45$0.31($0.14)$0.31$236.78 million$240.94 million
11/15/2022Q1 2023$0.37$0.65+$0.28$0.65$205.56 million$231.01 million
9/27/2022Q4 2022$0.40$0.59+$0.19$0.59$219.99 million$226.82 million
5/12/2022Q3 2022$0.37$0.47+$0.10$0.47$162.36 million$169.20 million    
2/16/2022Q2 2022$0.40$0.37($0.03)$0.37$151.61 million$157.67 million    
11/15/2021Q1$0.43$0.49+$0.06$0.49$144.69 million$147.50 million    
9/27/2021Q2 2021$0.35$41.00+$40.65$0.39$131.52 million$133.60 million    
5/18/2021Q1 2021$0.28$34.00+$33.72$0.32$111.21 million$112.30 million  
2/16/2021Q4 2020$0.23$29.00+$28.77$0.18$136.41 million$139.01 million  












Endava Earnings - Frequently Asked Questions

When is Endava's earnings date?

Endava has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 13th, 2024 based off last year's report dates. Learn more on DAVA's earnings history.

Did Endava beat their earnings estimates last quarter?

In the previous quarter, Endava (NYSE:DAVA) reported $0.39 earnings per share (EPS) to beat the analysts' consensus estimate of $0.35 by $0.04. Learn more on analysts' earnings estimate vs. DAVA's actual earnings.

How can I listen to Endava's earnings conference call?

The conference call for Endava's latest earnings report can be listened to online. Listen to Conference Call

How can I read Endava's conference call transcript?

The conference call transcript for Endava's latest earnings report can be read online. Read Transcript

How much revenue does Endava generate each year?

Endava (NYSE:DAVA) has a recorded annual revenue of $957.12 million.

How much profit does Endava generate each year?

Endava (NYSE:DAVA) has a recorded net income of $113.43 million. DAVA has generated $1.55 earnings per share over the last four quarters.

What is Endava's price-to-earnings ratio?

Endava (NYSE:DAVA) has a trailing price-to-earnings ratio of 43.72 and a forward price-to-earnings ratio of 55.55.

What is Endava's EPS forecast for next year?

Endava's earnings are expected to grow from $1.22 per share to $2.01 per share in the next year, which is a 64.75% increase.


More Earnings Resources from MarketBeat

This page (NYSE:DAVA) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -